Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Pasithea Therapeutics Corp (NQ: KTTA ) 6.050 +0.060 (+1.00%) Streaming Delayed Price Updated: 12:40 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Pasithea Therapeutics Corp < Previous 1 2 3 4 5 6 7 Next > Nasdaq Sharply Lower as Tech Selloff Weighs November 23, 2021 The Nasdaq Composite is sharply lower midday, as the tech selloff weighs on the benchmark, while the Dow Jones Industrial Average is up roughly 35 points, and the S&P 500 sits modestly in the red. Via Talk Markets Topics Stocks Exposures US Equities 36 Stocks Moving In Tuesday's Mid-Day Session November 23, 2021 Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) shares jumped 216.6% to $7.00 after the company announced its subsidiary Pasithea Clinics has been approved to provide... Via Benzinga DKS Stock: 14 Reasons Why Dick’s Sporting Goods Investors Are Taking an L Today November 23, 2021 Dick's Sporting Goods (DKS) stock isn't doing so hot on Tuesday following the release of its earnings report for the third quarter of 2021. Via InvestorPlace PTPI Stock: 11 Things to Know About Penny Stock Petros Pharmaceuticals as Shares Rocket 100%+ November 23, 2021 Petros Pharmaceuticals (PTPI) stock is surging higher on Tuesday following a filing with the U.S. Securities and Exchange Commission (SEC). Via InvestorPlace DLTR Stock Alert: The Dollar Tree Price Hike Giving Shares a Bump Today November 23, 2021 Dollar Tree (DLTR) stock is heading higher Tuesday after the company saw positive results from its recent price increase tests. Via InvestorPlace KTTA Stock: The Depression Nasal Spray News That Has Pasithea Therapeutics Investors Ecstatic Today November 23, 2021 Pasithea Therapeutics (KTTA) stock is rocketing higher on Tuesday after adding esketamine nasal spray to its U.K. offerings. Via InvestorPlace Mid-Morning Market Update: Markets Mostly Lower; Best Buy Posts Upbeat Q3 Earnings November 23, 2021 Following the market opening Tuesday, the Dow traded up 0.02% to 35,627.53 while the NASDAQ fell 0.58% to 15,762.28. The S&P also fell, dropping 0.14% to 4,676.49. The U.S.... Via Benzinga Topics Stocks Exposures US Equities Intranasal Ketamine Garnering A lot of Attention as an Effective Treatment For Depression November 23, 2021 Palm Beach, FL –November 23, 2021 – FinancialNewsMedia.com News Commentary – The COVID-19 pandemic is expected to have a significant positive impact on the growth of the global antidepressant market.... Via FinancialNewsMedia Exposures COVID-19 12 Health Care Stocks Moving In Tuesday's Pre-Market Session November 23, 2021 Gainers Pasithea Therapeutics (NASDAQ:KTTA) stock increased by 157.46% to $5.69 during Tuesday's pre-market session. The company's market cap stands at $75.1... Via Benzinga EXCLUSIVE: Pasithea's Depression Treatment, Esketamine Nasal Spray Added In Clinic Offerings In UK November 23, 2021 Pasithea Therapeutics Corp's (NASDAQ: KTTA) wholly-owned subsidiary, Pasithea Clinics, has been approved to provide esketamine nasal spray (Spravato) for treatment-resistant... Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session November 22, 2021 Gainers Qualigen Therapeutics (NASDAQ:QLGN Via Benzinga 44 Stocks Moving In Thursday's Mid-Day Session November 18, 2021 Gainers Longeveron Inc. (NASDAQ: LGVN) jumped 157% to $7.51. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the... Via Benzinga Exposures Product Safety 12 Health Care Stocks Moving In Thursday's Pre-Market Session November 18, 2021 Gainers Dicerna Pharmaceuticals (NASDAQ:DRNA) stock increased by 78.28% to $37.94 during Thursday's pre-market session. The market value of their outstanding shares is... Via Benzinga Mobile Mental Health: Coming to a Home Near You? November 18, 2021 Photo by Anna Shvets from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday November 18, 2021 Good morning, investor! We're getting right into the thick of it today with a look at the biggest pre-market stock movers for Thursday! Via InvestorPlace 24 Stocks Moving in Thursday's Pre-Market Session November 18, 2021 Gainers Sono Group N.V. (NASDAQ: SEV) rose 33% to $50.80 in pre-market trading. Sono Group shares climbed 155% on Wednesday after the company priced its IPO at $15 per share.... Via Benzinga Topics Initial Public Offering Exposures Securities Market Use of Ketamine for Mental Disorders Rising While New Therapies Emerge November 17, 2021 Palm Beach, FL –November 17, 2021 – FinancialNewsMedia.com News Commentary – The uses of Ketamine for a variety of therapies are growing. An expanding number of clinics are offering ketamine infusion... Via FinancialNewsMedia 12 Health Care Stocks Moving In Wednesday's Pre-Market Session November 17, 2021 Gainers Rockwell Medical (NASDAQ:RMTI) shares rose 47.27% to $0.71 during Wednesday's pre-market session. The company's market cap stands at $66.5 million. The... Via Benzinga EXCLUSIVE: Pasithea Clinics Launches In-Home Intravenous Ketamine Therapy In Major US Cities November 17, 2021 Pasithea Therapeutics Corp. (NASDAQ:KTTA), a biotechnology... Via Benzinga This Company Wants To Deliver Better Mental Health Straight to Your Door November 10, 2021 Photo by Thirdman from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner... Via Benzinga Knock, Knock: It's 2021, and Mental Health Is at Your Door November 05, 2021 Photo by Mo on Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of... Via Benzinga 64 Biggest Movers From Yesterday November 02, 2021 Gainers ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session November 01, 2021 Gainers Artelo Biosciences (NASDAQ:ARTL) stock moved upwards by 55.11% to $1.11 during Monday's regular session. As of 12:30 EST, this security is trading at a volume... Via Benzinga Pasithea and Evotec Team Up — Attempt to Make Headway on Brain Disorders November 01, 2021 Photo by Karolina Grabowska from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial... Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session October 28, 2021 Gainers Medigus (NASDAQ:MDGS) shares moved upwards by 12.04% to $1.62 during Thursday's pre-market session. The market value of their outstanding shares is at $38.6... Via Benzinga 30 Stocks Moving in Thursday's Pre-Market Session October 28, 2021 Gainers InflaRx N.V. (NASDAQ: IFRX) rose 47.9% to $4.23 in pre-market trading. Raymond James upgraded InflaRx from Outperform to Strong Buy and announced a $14 price target.... Via Benzinga Biotech Companies Are Embracing the Growing Psychedelic Drug Market To Confront a Global Increase in Depression and Anxiety October 27, 2021 Image by 3D Animation Production Company from Pixabay The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team... Via Benzinga Ketamine’s Potential As A Treatment For Depression Has Drawn Major Industry Attention October 27, 2021 Palm Beach, FL –October 27, 2021 – FinancialNewsMedia.com News Commentary – Among the race to see what psychedelic drugs can do, ketamine is a step ahead of all other drugs, because it has already been... Via FinancialNewsMedia Exposures Product Safety Pasithea Therapeutics Announces Successful Treatment of First Patients in the UK with Ketamine Infusion Therapy October 27, 2021 -- Pasithea Clinics commences IV ketamine infusion therapy in Knightsbridge, London, for the treatment of mental health disorders -- Miami Beach, FL / October 27, 2021 --... Via Benzinga EXCLUSIVE: Pasithea Administers First IV Ketamine Infusion Therapy In Depression Patients October 27, 2021 Pasithea Therapeutics Corp's (NASDAQ:KTTA) who... Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
